Concepedia

Dora W. Arneson

DW

6

Publications

402

Citations

6

H-Index

1979

Active since

Affiliations

University of Kansas Medical Center(Current)

MRIGlobal

National Cancer Institute

Dora W. Arneson is an author at University of Kansas Medical Center specializing in medicine, social sciences, and neuropharmacology.

Top concepts

Publications per year

1979–2006

6

Publications

6

Single-Dose and Multiple-Dose Administration of Indole-3-Carbinol to Women: Pharmacokinetics Based on 3,3′-Diindolylmethane

Gregory A. Reed, Dora W. Arneson, William C. Putnam et al. · Cancer Epidemiology Biomarkers & Prevention · 2006 · 163 citations

A phase II breast cancer chemoprevention trial of oral alpha-difluoromethylornithine: breast tissue, imaging, and serum and urine biomarkers.

Carol J. Fabian, Bruce F. Kimler, Deborah A Brady et al. · PubMed · 2002 · 97 citations

Breast Cancer Chemoprevention Phase I Evaluation of Biomarker Modulation by Arzoxifene, a Third Generation Selective Estrogen Receptor Modulator

Carol J. Fabian, Bruce F. Kimler, Julie Anderson et al. · Clinical Cancer Research · 2004 · 60 citations · Full text

Hyperpipecolic Acidemia

Dora W. Arneson · Archives of Neurology · 1982 · 31 citations

, , +9

Strychnine Therapy in Nonketotic Hyperglycinemia

Dora W. Arneson, Lawrence T. Chʼien, Philip Chance et al. · PEDIATRICS · 1979 · 28 citations

, , +16

Rows per page

1–5 of 6